Search results
Mastercard and LuLu Group forge multimarket partnership
Electronic Payments· 4 days agoThe companies will continue to offer a portfolio of co-branded credit cards via partners including ...
Emcure Pharmaceuticals IPO booked nearly 3x so far on Day 2. Check GMP and other details - The...
The Economic Times· 4 days agoAhead of the issue opening, the company raised Rs 582 crore from anchor investors. Marquee investors...
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details
The Economic Times· 4 days agoAhead of the issue opening, the company raised Rs 582 crore from anchor investors. Marquee investors...
ADNOC Drilling secures $733m contract for three newbuild island rigs
Offshore Technology· 4 days agoAdditionally, ADNOC Drilling and HH plan to work with AIQ, an AI company based in Abu Dhabi, to...
Shree Cement Summary: Latest Updates and Details | India Infoline
India Infoline· 4 days agoShree Cement Ltd Summary: Check out the latest management information and corporate updates of Shree Cement at India Infoline
Aramco, ADNOC reportedly weighing bids for Australia's Santos, analysts sceptical
VCCircle· 4 days agoSaudi Aramco and Abu Dhabi National Oil Company (ADNOC) have been separately considering bids for...
Federal Bank Summary: Latest Updates and Details | India Infoline
India Infoline· 4 days agoThe Bank has its representative offices in Abu Dhabi and Dubai and an IFSC Banking Unit (IBU) in Gujarat International Finance Tec-City (GIFT City).The ...
Former Zepto executive Ashish Shah joins DealShare as CFO
CNBC Awaaz· 4 days agoAshish Shah, the former Senior Vice President (SVP) of Finance at Zepto, has joined DealShare as its...
Max Holloway Calls Out Ilia Topuria for Lying About Title Fight Stall Accusation: ‘Guy Is Making up...
Pinkvilla· 4 days agoMax Holloway is not happy with Ilia Topuria. The UFC featherweight champion and the reigning UFC BMF...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 4 days agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...